CiteFacts · FDA Drug Shortages · FDA source
Fentanyl Citrate Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Available | 08/04/2026 |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Unavailable | 08/13/2026 |
| Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) | Limited Availability | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) | Available | 08/07/2026 |
Source facts
Grouped generic ingredient: Fentanyl Citrate Injection · 19 package records · Latest FDA row update: 08/13/2026
Therapeutic categories: Analgesia/Addiction, Pediatric
Dosage forms: Injection
Routes: INTRAMUSCULAR, INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.